BV
BioGeneration Ventures
Venture Capital · Founded 2006 · Naarden, Netherlands
Investing in the next generation of life sciences companies
BioGeneration Ventures’ biggest exits.
Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from BioGeneration Ventures’ transaction record.
Where BioGeneration Ventures’ portfolio is concentrated.
Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 38 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.
-
Netherlands22
-
Belgium5
-
USA4
-
UK3
-
Germany2
-
Canada1
-
Switzerland1
-
Health37
-
Kids1
-
Series A16
-
Seed14
-
Series B+2
-
Early Growth15
-
Late Growth12
-
Breakout Stage11
Inside BioGeneration Ventures’ portfolio.
The 34 highest-funded portfolio companies, of 38 tracked.
Ne
Ac
Ca
Ve
Az
No
Ci
Co
Ta
Rh
Va
Ki
Av
Co
Br
ar
Mi
Du
Sc
Du
Cr
Mu
Es
Fu
Ar
Me
La
Te
Ri
Fi
Ph
XS
Ta
PrWhere BioGeneration Ventures’ portfolio founders come from.
38 founders across the 38 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.
-
Netherlands21
-
Belgium7
-
Germany3
-
Switzerland2
-
United Kingdom2
-
Canada1
-
France1
-
United States1
-
Leiden University4
-
Utrecht University4
-
University of Aberdeen2
-
University of Amsterdam2
-
VU Amsterdam2
-
Avans University of Applied Sciences1
-
Cornell University1
-
Ghent University1
-
IMD Business School1
-
INSEAD Business School1
-
Galapagos2
-
ModiQuest2
-
UMC Utrecht2
-
Utrecht University2
-
VUmc2
-
Ablynx1
-
Africa Rising1
-
argenx1
-
Boer & Croon1
-
CeMM1
Similar investors.
Peers the API surfaces as most similar by portfolio shape, with Dealroom investor rank and portfolio scale.
